Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

It took six months of doctors probing and repeatedly scanning her abdomen to find the cause of Vicky Stinson's jaundice. By the time a doctor uttered the words "pancreatic cancer," Stinson's disease ...

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.

Get unlimited access to ad-free articles and exclusive content. An AI model developed at the Mayo Clinic in Rochester, Minnesota, detected abnormalities on patients’ CT scans up to three years before ...

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives. By Rebecca Robbins and Gina Kolata The reporters interviewed 13 patients with ...

Ben Sasse says he’s still alive thanks to "providence, prayer and a miracle drug." The 54-year-old former U.S. senator from Nebraska was told he had four months to live at most last December when he ...

Former Republican Sen. Ben Sasse is crediting a "miracle drug" currently under review by the Food and Drug Administration for helping him manage his pancreatic cancer, a diagnosis he announced in ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology. By Rebecca Robbins and Gina Kolata Two treatments being tested ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...